Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Karakas E, Simorowski N, Furukawa H (2011) Nature 475: 249-53 Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG (2008) Pharmacol Rev 60: 358-403 Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, Boone B, Shinohara ET, Hallahan DE (2006) Cancer Res 66: 11179-86 Asymptomatic Alzheimer disease: Defining resilience. Hohman TJ, McLaren DG, Mormino EC, Gifford KA, Libon DJ, Jefferson AL, Alzheimer's Disease Neuroimaging Initiative (2016) Neurology 87: 2443-2450 Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K (2004) J Neurosci 24: 257-68 Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Mathew JP, Mackensen GB, Phillips-Bute B, Grocott HP, Glower DD, Laskowitz DT, Blumenthal JA, Newman MF, Neurologic Outcome Research Group (NORG) of the Duke Heart Center (2009) Stroke 40: 880-7 IGF-I prevents glutamate-induced motor neuron programmed cell death. Vincent AM, Mobley BC, Hiller A, Feldman EL (2004) Neurobiol Dis 16: 407-16 Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V, Montine TJ (2000) Free Radic Biol Med 29: 1028-36 Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR (2013) Eur Neuropsychopharmacol 23: 960-71 Activation of N-methyl-D-aspartate receptors reverses desensitization of metabotropic glutamate receptor, mGluR5, in native and recombinant systems. Alagarsamy S, Rouse ST, Gereau RW, Heinemann SF, Smith Y, Conn PJ (1999) Ann N Y Acad Sci 868: 526-30 The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Tchantchou F, Tucker LB, Fu AH, Bluett RJ, McCabe JT, Patel S, Zhang Y (2014) Neuropharmacology 85: 427-39 Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity. Raman D, Milatovic SZ, Milatovic D, Splittgerber R, Fan GH, Richmond A (2011) Toxicol Appl Pharmacol 256: 300-13 Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors. Peavy RD, Conn PJ (1998) J Neurochem 71: 603-12 Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals. Duong T, Kim J, Ruley HE, Jo D (2014) PLoS One 9: e102517 Neurovascular unit on a chip: implications for translational applications. Alcendor DJ, Block FE, Cliffel DE, Daniels JS, Ellacott KL, Goodwin CR, Hofmeister LH, Li D, Markov DA, May JC, McCawley LJ, McLaughlin B, McLean JA, Niswender KD, Pensabene V, Seale KT, Sherrod SD, Sung HJ, Tabb DL, Webb DJ, Wikswo JP (2013) Stem Cell Res Ther 4 Suppl 1: S18 Delayed vision loss and therapeutic intervention after blast injury. Rex TS (2014) Invest Ophthalmol Vis Sci 55: 8342 Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML (2008) Invest Ophthalmol Vis Sci 49: 1437-46 SIRT1 activation confers neuroprotection in experimental optic neuritis. Shindler KS, Ventura E, Rex TS, Elliott P, Rostami A (2007) Invest Ophthalmol Vis Sci 48: 3602-9 Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Vega JN, Newhouse PA (2014) Curr Psychiatry Rep 16: 490 Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion. Gamboa J, Blankenship DA, Niemi JP, Landreth GE, Karl M, Hilow E, Sundararajan S (2010) Neuroscience 170: 846-57 Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo. Natarajan C, Yao SY, Zhang F, Sriram S (2013) J Neuroimmunol 265: 51-60 Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Rex TS, Wong Y, Kodali K, Merry S (2009) Exp Eye Res 89: 735-40 Trans-meningeal drug delivery to optic nerve ganglion cell axons using a nanoparticle drug delivery system. Grove K, Dobish J, Harth E, Ingram MC, Galloway RL, Mawn LA (2014) Exp Eye Res 118: 42-5 Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Huang J, May JM (2006) Brain Res 1097: 52-8 New approaches to neuroprotection in infant heart surgery. Albers EL, Bichell DP, McLaughlin B (2010) Pediatr Res 68: 1-9 Sigma receptors as potential therapeutic targets for neuroprotection. Nguyen L, Kaushal N, Robson MJ, Matsumoto RR (2014) Eur J Pharmacol 743: 42-7 Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. Kaushal N, Robson MJ, Rosen A, McCurdy CR, Matsumoto RR (2014) Eur J Pharmacol 724: 193-203 Role of sigma-1 receptors in neurodegenerative diseases. Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR (2015) J Pharmacol Sci 127: 17-29 Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. Milne GL, Morrow JD, Picklo MJ (2006) Neurosci Lett 405: 172-4 Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Li J, Liang X, Wang Q, Breyer RM, McCullough L, Andreasson K (2008) Neurosci Lett 438: 210-5 Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients. McLaughlin B, Gidday JM (2013) Transl Stroke Res 4: 104-13 Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Stanton PK, Potter PE, Aguilar J, Decandia M, Moskal JR (2009) Neuroreport 20: 1193-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.